Beneficial effects of levosimendan to wean patients from VA-ECMO: a systematic review and meta-analysis
Academic Article
Publication Date:
2023
Short description:
Beneficial effects of levosimendan to wean patients from VA-ECMO: a systematic review and meta-analysis / Bertini, P., Paternoster, G., Landoni, G., Falcone, M., Nocci, M., Costanzo, D., Brizzi, G., Romani, M., Esposito, A., Guarracino, F.. - In: MINERVA CARDIOLOGY AND ANGIOLOGY. - ISSN 2724-5772. - 71:5(2023), pp. 564-574. [10.23736/S2724-5683.22.06054-9]
abstract:
Patients with refractory cardiogenic shock can benefit from veno-arterial extracorporeal membrane oxygenation (VA-ECMO). The use of levosimendan in VA-ECMO patients may facilitate weaning and enhance survival.
Iris type:
1.1.1 Articolo in rivista - Review
List of contributors:
Bertini, Pietro; Paternoster, Gianluca; Landoni, Giovanni; Falcone, Marco; Nocci, Matteo; Costanzo, Diego; Brizzi, Giulia; Romani, Matteo; Esposito, Andrea; Guarracino, Fabio
Published in: